ArticlePharmaceuticals (Basel, Switzerland)2022

Mitochondrion-Targeted NIR Therapeutic Agent Suppresses Melanoma by Inducing Apoptosis and Cell Cycle Arrest via E2F/Cyclin/CDK Pathway.

Changzhen Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.